Selected article for: "acute lung injury and lung tissue"
Author: Al-Gabri, Naif A; Saghir, Sultan A M; Al-Hashedi, Sallah A; El-Far, Ali H; Khafaga, Asmaa F; Swelum, Ayman A; Al-wajeeh, Abdullah S; Mousa, Shaker A; Abd El-Hack, Mohamed E; Naiel, Mohammed A E; El-Tarabily, Khaled A
Title: Therapeutic Potential of Thymoquinone and Its Nanoformulations in Pulmonary Injury: A Comprehensive Review
  • Cord-id: 00ba323t
  • Document date: 2021_7_27
    • ID: 00ba323t
    Snippet: As a crucial organ, the lung is exposed to various harmful agents that may induce inflammation and oxidative stress, which may cause chronic or acute lung injury. Nigella sativa, also known as black seed, has been widely used to treat various diseases and is one of the most extensively researched medicinal plants. Thymoquinone (TQ) is the main component of black seed volatile oil and has been proven to have antioxidant, anti-inflammatory, and antineoplastic properties. The potential therapeutic
    Document: As a crucial organ, the lung is exposed to various harmful agents that may induce inflammation and oxidative stress, which may cause chronic or acute lung injury. Nigella sativa, also known as black seed, has been widely used to treat various diseases and is one of the most extensively researched medicinal plants. Thymoquinone (TQ) is the main component of black seed volatile oil and has been proven to have antioxidant, anti-inflammatory, and antineoplastic properties. The potential therapeutic properties of TQ against various pulmonary disorders have been studied in both in vitro and in vivo studies. Furthermore, the application of nanotechnology may increase drug solubility, cellular absorption, drug release (sustained or control), and drug delivery to lung tissue target sites. As a result, fabricating TQ as nanoparticles (NPs) is a potential therapeutic approach against a variety of lung diseases. In this current review, we summarize recent findings on the efficacy of TQ and its nanotypes in lung disorders caused by immunocompromised conditions such as cancer, diabetes, gastric ulcers, and other neurodegenerative diseases. It is concluded that TQ nanoparticles with anti-inflammatory, antioxidant, antiasthma, and antitumor activity may be safely applied to treat lung disorders. However, more research is required before TQ nanoparticles can be used as pharmaceutical preparations in human studies.

    Search related documents:
    Co phrase search for related documents
    • actin cytoskeleton and acute ards respiratory distress syndrome: 1
    • actin cytoskeleton and acute respiratory syndrome: 1
    • actin depolymerization and acute ards respiratory distress syndrome: 1
    • actin depolymerization and acute respiratory syndrome: 1
    • activator protein and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6
    • activator protein and acute lung injury: 1, 2, 3, 4
    • activator protein and acute pneumonia: 1
    • activator protein and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • activator protein and administration route: 1
    • active ingredient and acute ards respiratory distress syndrome: 1
    • active ingredient and acute lung injury: 1, 2
    • active ingredient and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • activity enhance and acute ards respiratory distress syndrome: 1
    • activity enhance and acute lung injury: 1, 2
    • activity enhance and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • acute respiratory syndrome and adjuvant prophylactic: 1, 2